The U.S. and Europe Still Lead mAb Approvals, but China’s Presence Is Growing
Global monoclonal antibody approvals by region of origin, by year of first global approval, 2017–25
Stacked column chart of global monoclonal antibody approvals by region of origin from 2017 to 2025, where the U.S. or Europe leads each year but China's share grows noticeably from 2021 onward.
